Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ANIK compared with VRCA: revenue, margins and what each company keeps, and the suppliers and customers both name
ANIK
Anika Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
VRCA
Verrica Pharmaceuticals Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ANIK
Anika Therapeutics, Inc.
vs
VRCA
Verrica Pharmaceuticals Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ANIK, solid
VRCA, dashed
ANIK
Anika Therapeutics, Inc.
Change
14.29
▼
−26.05%
· post 14.29
Mkt cap
$194.9M
Revenue
$31M
Q3 FY26
Revenue
$113M
FY25
VRCA
Verrica Pharmaceuticals Inc.
Change
3.35
▲
+8.33%
· post 3.35
Closed
Nov 6 '26
Mkt cap
$54.8M
Revenue
$6M
Q2 FY26
Revenue
$36M
FY25
vs
Compare
Closed
Nov 6 '26
ANIK
Anika Therapeutics, Inc.
vs
VRCA
Verrica Pharmaceuticals Inc.
14.29
▼
−26.05%
post 14.29
Price
3.35
▲
+8.33%
post 3.35
$194.9M
Mkt cap
$54.8M
Q3 FY26
$31M
Revenue
$6M
Q2 FY26
FY25
$113M
Revenue
$36M
FY25
Change
Change
ANIK
14.29
▼
−26.05%
vs
VRCA
3.35
▲
+8.33%
Closed
Nov 6 '26